Funded Health Care Startups in Saint Paul
Within this Saint Paul, MN health care set of 12 recent entries, the largest disclosed round is Aria CV’s $31M on 2020-02-25, which sits far above the rest…
Within this Saint Paul, MN health care set of 12 recent entries, the largest disclosed round is Aria CV’s $31M on 2020-02-25, which sits far above the rest of the disclosed amounts (for example, 2023–2024 disclosed rounds include $6M for BetterYou on 2023-12-06 and $5M for Phraxis on 2022-03-24, while several entries are at $2M, $1M, $400K, or $10K). By stage, Series Unknown and undisclosed amounts are frequent: five rows are labeled “Series Unknown” and two are “undisclosed,” spanning multiple years rather than a single late-cycle event.
Dates cluster at the top end of the window: five of the 12 rows have round dates in 2024 (from Cardio Flow on 2024-06-21 back to Egg Medical on 2024-01-26), while the oldest shown round is Aria CV on 2020-02-25. Sector naming is consistent across all rows (“Health Care”), but the disclosed funding sizes show clear bifurcation between a small number of large checks ($31M, $10M, $6M, $5M, $3M) and a larger tail of comparatively smaller rounds.
Most recent rounds
12 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in this Saint Paul health care slice, and how does it compare to the others?
Aria CV’s disclosed $31M on 2020-02-25 dwarfs the other disclosed amounts in the list, with the next-highest disclosed amounts being $10M (Oncodea, 2022-12-06) and $6M (BetterYou, 2023-12-06). Several other disclosed rounds fall much lower, including Cardio Flow at $400K (2024-06-21) and Oncodea at $10K (2022-12-06).
How concentrated are the funding dates—are most rounds occurring in a recent window?
Yes. Five of the 12 entries are dated in 2024, including Cardio Flow ($400K, 2024-06-21), Egg Medical ($3M, 2024-01-26), and Joshin ($1M, 2024-01-10). The list also shows a longer tail back to 2020, anchored by Aria CV on 2020-02-25.
What does the stage mix look like—does a particular label dominate the disclosed rounds?
“Series Unknown” appears on five rows (e.g., Cardio Flow 2024-06-21; Egg Medical 2024-01-26; NXgenPort 2023-06-06), and “undisclosed” appears on two rows (Visante 2024-02-12; Rainbow Health 2023-11-09). Defined stages that do appear include Series A for BetterYou ($6M on 2023-12-06), Series D for Phraxis ($5M on 2022-03-24), and Private Equity for Ellie Mental Health (amount undisclosed, 2022-05-02).
Which entries are recent enough to matter for near-term outreach based on the displayed dates?
Within the most recent entries shown, Cardio Flow closes on 2024-06-21 ($400K) and Visante is dated 2024-02-12 (undisclosed). The same 2024 cluster also includes Egg Medical (2024-01-26, $3M) and Joshin (2024-01-10, $1M), while BetterYou (2023-12-06, $6M) sits just outside the 2024 window.
Are there funding-size outliers worth prioritizing for diligence or competitive mapping?
The main outlier is Aria CV’s $31M (2020-02-25), which is substantially above the rest of the disclosed checks. On the next tier, Oncodea’s $10K (2022-12-06) contrasts sharply with other larger disclosed rounds like BetterYou’s $6M (2023-12-06) and Phraxis’s $5M (2022-03-24), suggesting wide variance in deal size even within the same city/sector labeling.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.